Characteristics of Multisystem Inflammatory Syndrome in Children During COVID-19

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, APRIL 6, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2021.0630?guestAccessKey=145e1ae6-2d09-4378-897a-90dc868ec13e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040621

 

What The Study Did: The clinical and other characteristics of multisystem inflammatory syndrome in children in the United States, a condition that occurs in association with the COVID-19 pandemic, are described in this study.

Authors: Ermias D. Belay, M.D., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2021.0630)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.